Joule Unlimited Technologies is a technology company.
Joule Unlimited Technologies has raised $100.0M across 2 funding rounds.
Joule Unlimited Technologies has raised $100.0M in total across 2 funding rounds.
Joule Unlimited Technologies, Inc. (formerly Joule Biotechnologies) was a biotechnology company developing a CO2-to-fuel production platform using engineered cyanobacteria to convert waste CO2, sunlight, non-fresh water, and nutrients into renewable fuels like ethanol, diesel, jet fuel, and gasoline.[1][3] It targeted the alternative energy market, aiming to produce fuels without agricultural land, fresh water, or crops, with claims of over 20,000 gallons per acre per year at costs competitive with $50/barrel crude oil.[3] The company served potential industrial and transportation fuel markets but shut down in August 2017 after failing to secure additional funding following a demonstration plant in Hobbs, New Mexico.[3]
Privately held and founded in 2007 in Bedford, Massachusetts, Joule raised over $160-190 million from investors like Flagship Ventures, with operations also in The Hague, Netherlands.[1][2][3] It employed around 11-49 people and generated $5-10 million in revenue, primarily through R&D in clean tech, sustainability, and oil/gas biotech sectors.[1][2]
Joule Unlimited was founded in 2007 within Flagship VentureLabs by Noubar Afeyan and David Berry, both key figures in biotech venture creation.[3] The idea emerged from synthetic biology advances, focusing on genetically modified cyanobacteria to reverse combustion by producing hydrocarbons directly from CO2 and solar energy, bypassing traditional biofuel constraints like feedstocks.[1][3]
Early traction included a 2010 patent for the altered bacterium and building a demonstration plant in Hobbs, New Mexico.[1][3] A pivotal 2012 partnership with Audi accelerated commercialization of e-ethanol (Sunflow-E) and e-diesel (Sunflow-D).[3] Despite raising over $160 million led by Flagship Ventures, the company ceased operations in 2017 after ten years, unable to raise further capital.[1][3]
Joule rode the early 2010s wave of synthetic biology and clean energy innovation, addressing climate-driven needs for carbon-neutral fuels amid rising oil prices and CO2 regulations.[1][3] Timing aligned with post-2008 energy transition pushes, where biotech promised to disrupt fossil fuels by recycling emissions into drop-in replacements for gasoline, diesel, and jet fuel.[3]
Market forces like industrial CO2 waste abundance and solar cost declines favored its model, influencing the ecosystem by pioneering "reverse combustion" concepts that inspired later carbon capture and e-fuels efforts (e.g., Audi's ongoing e-diesel work).[3] Though it failed commercially, Joule's IP and demos advanced the field, highlighting scalability challenges in algal biofuels.[1][3]
Joule Unlimited represented bold ambition in biotech fuels but ultimately succumbed to funding hurdles in a capital-intensive sector, shutting down in 2017 with no active operations today.[3] Post-closure, its technology and patents may have been acquired or influenced successors in synthetic biology and e-fuels, amid trends like falling solar costs, stricter emissions rules, and direct air capture advances.
Looking ahead, revived interest in CO2 utilization—driven by net-zero goals—could see Joule-like platforms resurface through larger players, but economic viability remains key. Its legacy underscores the high-risk path from lab to scale in clean energy, tying back to its core promise of sustainable fuel abundance from sunlight and air.[1][3]
Joule Unlimited Technologies has raised $100.0M in total across 2 funding rounds.
Joule Unlimited Technologies's investors include ARCH Venture Partners, Borealis Ventures, Catalio Capital, Flagship Ventures, InterWest, NanoDimension, Petri, Polaris Partners, Vivo Capital, Wildcat Ventures.
Joule Unlimited Technologies has raised $100.0M across 2 funding rounds. Most recently, it raised $70.0M Series C in January 2012.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 1, 2012 | $70.0M Series C | ARCH Venture Partners, Borealis Ventures, Catalio Capital, Flagship Ventures, InterWest, NanoDimension, Petri, Polaris Partners, Vivo Capital, Wildcat Ventures | |
| Apr 1, 2010 | $30.0M Series B | ARCH Venture Partners, Borealis Ventures, Catalio Capital, Flagship Ventures, InterWest, NanoDimension, Petri, Polaris Partners, Vivo Capital, Wildcat Ventures |